Medicine
North American Coral Snake Antivenin (Equine) 250 units/10 mL powder for injection
North American Coral Snake Antivenin (Equine) 250 units/10 mL powder for injection is a prescription medicine containing Coral snake (micrurus fulvius) immune globulin antivenin (equine) for intravenous use, marketed by Wyeth Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not freeze. Store vials between 2 and 8°C (36 and 46° F).
Key facts
- Active ingredient (INN)
- Coral snake (micrurus fulvius) immune globulin antivenin (equine)
- Brand
- North American Coral Snake Antivenin (Equine)
- Strength
- 250 units/10 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Wyeth Pharmaceuticals
- Manufacturer
- Wyeth Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store vials between 2 and 8°C (36 and 46° F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 October 2016
- Identifiers
- RxCUI 1858981DailyMed set ID 6d0f94b4-82ca-37c7-edb0-4f0702cf6c8dNDC 0008-0423Application BLA101099
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 10 mL in 1 vial | 0008-0423-03 | Wyeth Pharmaceuticals | 12 October 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Coral snake (micrurus fulvius) immune globulin antivenin (equine) is a prescription medicine. It is available as powder for injection for intravenous use. MedsAcross supplies Coral snake (micrurus fulvius) immune globulin antivenin (equine) for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Coral snake (micrurus fulvius) immune globulin antivenin (equine)For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- North American Coral Snake Antivenin (Equine) prescribing information (Wyeth Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need North American Coral Snake Antivenin (Equine) 250 units/10 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.